rewirebio.iobenchmarks
Configuration

Protenix — FoldBench published inference

5 seeds × 5 samples, 10 recycles; highest model ranking score. Paper-specific input/code adjustments; H800 80GB inference.

9 evaluations · 35 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

9 evaluations · 35 results. Different protocols are not a single leaderboard.

Sorted by lDDT (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetlDDTFoldBench success rateCAPRI interface RMSDCAPRI ligand RMSDGDT tsRMSDTM scorelDDT-LPlDDT-PLI
Protenix — FoldBench published inferenceEvaluationFoldBench protein-monomer published full-set assessment, FoldBench protein-monomer published targets0.86 (best in column)Not reportedNot reportedNot reported0.9 (best in column)2.04 (best in column)0.93 (best in column)Not reportedNot reported
Protenix — FoldBench published inferenceEvaluationFoldBench antibody-antigen published full-set assessment, FoldBench antibody-antigen published targets0.8534.1%8.9130.4Not reportedNot reportedNot reportedNot reportedNot reported
Protenix — FoldBench published inferenceEvaluationFoldBench protein-dna published full-set assessment, FoldBench protein-dna published targets0.8368.4%5.0811.6Not reportedNot reportedNot reportedNot reportedNot reported
Protenix — FoldBench published inferenceEvaluationFoldBench protein-peptide published full-set assessment, FoldBench protein-peptide published targets0.8377.1% (best in column)2.93 (best in column)8.44 (best in column)Not reportedNot reportedNot reportedNot reportedNot reported
Protenix — FoldBench published inferenceEvaluationFoldBench protein-protein published full-set assessment, FoldBench protein-protein published targets0.8168.2%7.2217.5Not reportedNot reportedNot reportedNot reportedNot reported
Protenix — FoldBench published inferenceEvaluationFoldBench protein-rna published full-set assessment, FoldBench protein-rna published targets0.7544.8%8.8822.3Not reportedNot reportedNot reportedNot reportedNot reported
Protenix — FoldBench published inferenceEvaluationFoldBench rna-monomer published full-set assessment, FoldBench rna-monomer published targets0.59Not reportedNot reportedNot reported0.559.240.38Not reportedNot reported
Protenix — FoldBench published inferenceEvaluationFoldBench dna-monomer published full-set assessment, FoldBench dna-monomer published targets0.44Not reportedNot reportedNot reported0.527.40.28Not reportedNot reported
Protenix — FoldBench published inferenceEvaluationFoldBench protein-ligand published full-set assessment, FoldBench protein-ligand published targetsNot reported50.7%Not reportedNot reportedNot reportedNot reportedNot reported0.890.7
All 35 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench antibody-antigen published full-set assessment
Dataset: FoldBench antibody-antigen published targets
8.91 CAPRI interface RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench antibody antigen protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, iRMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench antibody-antigen published full-set assessment
Dataset: FoldBench antibody-antigen published targets
0.85 lDDT
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench antibody antigen protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, LDDT row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench antibody-antigen published full-set assessment
Dataset: FoldBench antibody-antigen published targets
30.4 CAPRI ligand RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench antibody antigen protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, lRMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench antibody-antigen published full-set assessment
Dataset: FoldBench antibody-antigen published targets
34.1% FoldBench success rate
percent · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench antibody antigen protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, Success rate row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench dna-monomer published full-set assessment
Dataset: FoldBench dna-monomer published targets
0.52 GDT ts
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench dna monomer protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, dna-monomer block, GDT-TS row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench dna-monomer published full-set assessment
Dataset: FoldBench dna-monomer published targets
0.44 lDDT
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench dna monomer protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, dna-monomer block, LDDT row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench dna-monomer published full-set assessment
Dataset: FoldBench dna-monomer published targets
7.4 RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench dna monomer protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, dna-monomer block, RMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench dna-monomer published full-set assessment
Dataset: FoldBench dna-monomer published targets
0.28 TM score
unitless · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench dna monomer protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, dna-monomer block, TM-score row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-dna published full-set assessment
Dataset: FoldBench protein-dna published targets
5.08 CAPRI interface RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein dna protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-dna block, iRMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-dna published full-set assessment
Dataset: FoldBench protein-dna published targets
0.83 lDDT
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein dna protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-dna block, LDDT row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-dna published full-set assessment
Dataset: FoldBench protein-dna published targets
11.6 CAPRI ligand RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein dna protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-dna block, lRMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-dna published full-set assessment
Dataset: FoldBench protein-dna published targets
68.4% FoldBench success rate
percent · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein dna protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-dna block, Success rate row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-ligand published full-set assessment
Dataset: FoldBench protein-ligand published targets
0.89 lDDT-LP
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein ligand protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-ligand block, LDDT-LP row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-ligand published full-set assessment
Dataset: FoldBench protein-ligand published targets
0.7 lDDT-PLI
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein ligand protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-ligand block, LDDT-PLI row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-ligand published full-set assessment
Dataset: FoldBench protein-ligand published targets
50.7% FoldBench success rate
percent · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein ligand protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-ligand block, Success rate row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-monomer published full-set assessment
Dataset: FoldBench protein-monomer published targets
0.9 GDT ts
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein monomer protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-monomer block, GDT-TS row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-monomer published full-set assessment
Dataset: FoldBench protein-monomer published targets
0.86 lDDT
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein monomer protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-monomer block, LDDT row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-monomer published full-set assessment
Dataset: FoldBench protein-monomer published targets
2.04 RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein monomer protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-monomer block, RMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-monomer published full-set assessment
Dataset: FoldBench protein-monomer published targets
0.93 TM score
unitless · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein monomer protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-monomer block, TM-score row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-peptide published full-set assessment
Dataset: FoldBench protein-peptide published targets
2.93 CAPRI interface RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein peptide protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, iRMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-peptide published full-set assessment
Dataset: FoldBench protein-peptide published targets
0.83 lDDT
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein peptide protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, LDDT row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-peptide published full-set assessment
Dataset: FoldBench protein-peptide published targets
8.44 CAPRI ligand RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein peptide protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, lRMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-peptide published full-set assessment
Dataset: FoldBench protein-peptide published targets
77.1% FoldBench success rate
percent · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein peptide protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, Success rate row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-protein published full-set assessment
Dataset: FoldBench protein-protein published targets
7.22 CAPRI interface RMSD
angstrom · lower

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein protein protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-protein block, iRMSD row, Protenix column; Table 1 assessable count
Configuration: Protenix — FoldBench published inferenceProtocol: FoldBench protein-protein published full-set assessment
Dataset: FoldBench protein-protein published targets
0.81 lDDT
fraction · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

foldbench protein protein protenix

Not reported

Aggregation: source table mean

FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-protein block, LDDT row, Protenix column; Table 1 assessable count

Source checking is not independent reproduction. Release 2026-11-02-a7f03c9e55a5.

Use this configuration

How it works, versions and access

Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

2 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-02-a7f03c9e55a5
Property and statementOriginal source and locationReview and provenance
Facets: method types
1 values
  • foundation_model
Individual claims
Benchmarking all-atom biomolecular structure prediction with FoldBench

Original source ↗

Matches other AlphaFold 3 and Chai-1 configurations

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:23:29Z

conflicting claim

["automated-source-review"] · 2026-10-12

Audit details

Correct the method type from none to foundation_model (use-case baseline review 2026-10-12, table 2). The review did not read FoldBench. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. See docs/reviews/2026-10-12-method-type-corrections.md.

Conflicting source claim: "[\"foundation_model\"]". Claim record status: source_checked.

Field: facets.method_types

Claim: metadata-correction-tags-20261012-736ffa8de7e4bcb7cd58

Source artifact SHA-256: 3104bc7a0c5dd138421edfae72008fe1369b18192702fb7474a2517aece31928

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Facets: method types
1 values
  • foundation_model
Individual claims
FoldBench supplementary target coverage and performance

Original source ↗

Matches other AlphaFold 3 and Chai-1 configurations

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information to 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:26:52Z

conflicting claim

["automated-source-review"] · 2026-10-12

Audit details

Correct the method type from none to foundation_model (use-case baseline review 2026-10-12, table 2). The review did not read FoldBench. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. See docs/reviews/2026-10-12-method-type-corrections.md.

Conflicting source claim: "[\"foundation_model\"]". Claim record status: source_checked.

Field: facets.method_types

Claim: metadata-correction-tags-20261012-736ffa8de7e4bcb7cd58

Source artifact SHA-256: c699bd6b7ef8277ce4f89d12ff2365cd7a199dbc7eb4b674aeba4e62da92d5bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-02-a7f03c9e55a5 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: ucc-research-config-foldbench-protenix

method types
foundation_model
review
method: automated-source-review; reviewed at: 2026-09-30T21:43:56Z; note: Primary-source table transcription and scope review; no independent reproduction or human scientific review.; reviewer note: role: research coverage worker; reviewer: codex
code commit
ca0170c256cc1e39ac2b4f330401a6419f0e97f3
samples
25
recycles
10
selection
highest model ranking score
missing metadata
weights sha256: reason: unextracted
Related records

Suggest a correction